GATA5 harbours a function in inhibiting malignant behaviour of HCC cells, the mechanism maybe involve in dysregulation of Wnt/β‐catenin signalling and suppression of reprogramming gene expression. Here, GATA5 is linked to hepatocellular carcinoma.